Cloning and expression of apolipoprotein E3 and its variant apoE2 and apoE4

Abstract

In order to obtain three isoforms of apolipoprotein E (apoE), the cDNA encoding apoE3 was obtained by RT-PCR from normal human liver tissue. Site-directed mutagenesis was used to obtain the cDNAs encoding apoE2 and apoE4 isoforms. The 3 cDNAs were subcloned into vector pGEM-3Z and verified by DNA sequencing. The expression recombinant which can express the target protein as a (His) 6-tagged fusion was constructed by subcloning apoE cDNA into vector pT7-PL. The purified proteins were gained by Ni-NTA column. The SDS-PAGE results revealed the 6 His fusion proteins (apoE2, apoE3 and apoE4) were correctly expressed and purified successfully.

Keywords

apoE / gone cloning / site-directed mutation / gene expression

References

[1] ShoreV G, ShoreB. Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry, 1973, 12(3): 502-507

[2] MahleyR W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 1988, 240(4852): 622-630

[3] PepeM G, CurtissL K. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. J Immunol, 1986, 136(10): 3716-3723

[4] WeisgraberK H, MahleyR W. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J, 1996, 10: 1485-1485

[5] RallS C, WeisgraberK H, MahleyR W. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem, 1982, 257(8): 4171-4178

[6] WeisgraberK H, RallS C, MahleyR W. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apoE isoforms. J Biol Chem, 1981, 256(17): 9077-9083

[7] LucotteG, DavidF, VisvikisS, et al.. Apolipoprotein E4 allele and Alzheimer's disease. Lancet, 1993, 342(8882): 1309-1309

[8] BernsteinM S, CostanzaM C, JamesR W, et al.. Physical activity may modulate effects of ApoE genotype on lipid profile. Arterioscler Thromb Vasc Biol, 2002, 22(1): 133-140